Kazia Therapeutics (KZIA) Return on Invested Capital (2009 - 2011)

Kazia Therapeutics (KZIA) posted Return on Invested Capital of 0.02% for Q4 2011, up 44.59% on a QoQ basis from 0.03% in Q4 2010, and up 1.0% year-over-year from 0.02% in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of Return on Invested Capital data on file, last reported at 0.02% in Q4 2011.

  • In Q4 2011, Return on Invested Capital rose 1.0% year-over-year to 0.02%; the TTM figure through Dec 2011 stood at 0.02% (up 1.0% YoY), while the FY2025 annual figure was 0.05%, down 2.0% from the prior year.
  • Return on Invested Capital climbed to 0.02% in Q4 2011, from 0.03% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.02% in Q4 2011 and bottomed at 0.03% in Q4 2010.
  • A 3-year average of 0.02% and a median of 0.02% in 2009 frame the typical range for Return on Invested Capital.
  • Annual changes were most pronounced in 2010 — Return on Invested Capital retreated 1 bps — and 2011, when it increased 1 bps.
  • Year by year, Return on Invested Capital stood at 0.02% in 2009, then sank by 68 bps to 0.03% in 2010, then jumped by 45 bps to 0.02% in 2011.
  • The last three Return on Invested Capital figures came in at 0.02% (Q4 2011), 0.03% (Q4 2010), and 0.02% (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -0.01%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.00%
7 Evaxion A 62.56 Bn 62.54 Bn - -0.01%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.01%
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -0.02%
Dec 31, 2010 -0.03%
Dec 31, 2009 -0.02%